1 Klein EA, "Vitamin E and the risk of prostate cancer : the Selenium and Vitamin E Cancer Prevention Trial(SELECT)" 306 : 1549-1556, 2011
2 Andriole GL, "Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer : results of a randomized, double-blind, placebocontrolled clinical trial. PLESS Study Group. Proscar Longterm Efficacy and Safety Study" 52 : 195-201, 1998
3 Thompson IM, "The influence of finasteride on the development of prostate cancer" 349 : 215-224, 2003
4 Thompson IM, "Effect of finasteride on the sensitivity of PSA for detecting prostate cancer" 98 : 1128-1133, 2006
5 Andriole GL, "Effect of dutasteride on the risk of prostate cancer" 362 : 1192-1202, 2010
6 Cohen YC, "Detection bias due to the effect of finasteride on prostate volume : a modeling approach for analysis of the Prostate Cancer Prevention Trial" 99 : 1366-1374, 2007
7 Sarkar RR, "Association of treatment with 5α-reductase inhibitors with time to diagnosis and mortality in prostate cancer" 179 : 812-819, 2019
1 Klein EA, "Vitamin E and the risk of prostate cancer : the Selenium and Vitamin E Cancer Prevention Trial(SELECT)" 306 : 1549-1556, 2011
2 Andriole GL, "Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer : results of a randomized, double-blind, placebocontrolled clinical trial. PLESS Study Group. Proscar Longterm Efficacy and Safety Study" 52 : 195-201, 1998
3 Thompson IM, "The influence of finasteride on the development of prostate cancer" 349 : 215-224, 2003
4 Thompson IM, "Effect of finasteride on the sensitivity of PSA for detecting prostate cancer" 98 : 1128-1133, 2006
5 Andriole GL, "Effect of dutasteride on the risk of prostate cancer" 362 : 1192-1202, 2010
6 Cohen YC, "Detection bias due to the effect of finasteride on prostate volume : a modeling approach for analysis of the Prostate Cancer Prevention Trial" 99 : 1366-1374, 2007
7 Sarkar RR, "Association of treatment with 5α-reductase inhibitors with time to diagnosis and mortality in prostate cancer" 179 : 812-819, 2019